Interrogating and manipulating mitochondrial ROS, energetics and proteomics

探究和操纵线粒体 ROS、能量学和蛋白质组学

• 批准号: 7817957
• 负责人: PETER S RABINOVITCH
• 金额: $ 25.97万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7817957
• 关键词: Aging; Angiotensin II; Antioxidants; Data; Development; Disease; Disease model; Elements; Functional disorder; Heart; Heart Diseases; Human; Isotope Labeling; Laboratories; Magnetic Resonance; Measurement; Measures; Methodology; Methods; Mitochondria; Mitochondrial Proteins; Monitor; Mus; Muscle; Myocardium; Optics; Organ; Peptides; Play; Protein Biosynthesis; Proteome; Proteomics; Role; Scientist; Skeletal Muscle; Spectrum Analysis; Stress; Structure; Techniques; Technology; Time; Tissues; Validation; Zidovudine; age related; base; in vivo; muscle stress; novel; public health relevance; response; sarcopenia; tool

DESCRIPTION (provided by applicant): We propose a response to Challenge 06-AG-104 that incorporates development of three novel tools and technologies that can alter or interrogate human mitochondrial function in vivo. We will then apply these tools to the study of aging heart and muscle in order to demonstrate that they can enable an integrated understanding of the role of mitochondrial ROS, mitochondrial energetics and changes in mitochondrial protein composition and turnover in age-related sarcopenia and heart disease. In Aim 1 we will manipulate in vivo mitochondrial structure and activity by the use of novel mitochondrial targeted antioxidant and protective peptides. This is important in human aging because data from our and other laboratories indicate that mitochondria and mitochondrial ROS play a critical role in age-related declines in organ function. In Aim 2 we will apply novel magnetic resonance and optical spectroscopy techniques to measure O2 and ATP fluxes simultaneously to create a totally non-invasive and more versatile measure of mitochondrial function. In Aim 3 w e will use novel proteomic methodologies to characterize the structural basis of changes in mitochondrial function in aging tissues in vivo and tissues protected by antioxidant peptides. This will include measurement of global mitochondrial protein abundance and mitochondrial proteome-wide differences in protein syntheses and turnover rates using in vivo heavy isotope labeling. In each of these aims we will apply and validate the tools developed using two tissues for which there is abundant evidence for the critical role of mitochondria and, mitochondrial ROS in aging: heart and skeletal muscle. We will examine healthy young and old muscle, plus young hearts stressed with angiotensin II and young muscle stressed by AZT treatment. The combined use of these three methods allows us to manipulate human mitochondrial structure and activity at the same time as we monitor and measure mitochondrial function and dysfunction in aging tissues. Thus, we can obtain an integrated assessment of the in vivo inter-relationships of mitochondrial, ROS, energetics and proteomics in aging and disease. PUBLIC HEALTH RELEVANCE: This response to Challenge 06-AG-104 incorporates three responsive elements that will be used together in concert to provide an integrated assessment of the in vivo inter-relationships of mitochondrial, ROS, energetics and proteomics in aging and disease: 1) we will manipulate in vivo mitochondrial structure and activity by the use of novel mitochondrial targeted antioxidant and protective peptides; 2) we will use novel magnetic resonance and optical spectroscopy tools to create totally non-invasive and more versatile measures of mitochondrial energetics in vivo, and 3) we will use novel proteomic tools to characterize the structural basis of changes in mitochondrial function. The combined use of these methods allows us to manipulate human mitochondrial structure and activity at the same time as we monitor and measure mitochondrial function and dysfunction in aging tissues.

描述（由申请方提供）：我们提出了对挑战06-AG-104的响应，其中包括开发了三种可在体内改变或询问人线粒体功能的新型工具和技术。然后，我们将这些工具应用于衰老的心脏和肌肉的研究，以证明它们可以使线粒体ROS的作用，线粒体能量学和线粒体蛋白质组成和营业额的变化在年龄相关的肌肉减少症和心脏病的综合理解。在目标1中，我们将通过使用新型线粒体靶向抗氧化剂和保护肽来操纵体内线粒体结构和活性。这在人类衰老中很重要，因为我们和其他实验室的数据表明，线粒体和线粒体ROS在与年龄相关的器官功能下降中起着关键作用。在目标2中，我们将应用新的磁共振和光谱技术来同时测量O2和ATP通量，以创建一个完全非侵入性和更通用的线粒体功能测量。在目标3中，我们将使用新的蛋白质组学方法来表征体内衰老组织和抗氧化肽保护组织中线粒体功能变化的结构基础。这将包括使用体内重同位素标记测量全球线粒体蛋白质丰度和线粒体蛋白质组范围内蛋白质合成和周转率的差异。在这些目标中，我们将应用和验证使用两种组织开发的工具，其中有大量证据表明线粒体和线粒体ROS在衰老中的关键作用：心脏和骨骼肌。我们将检查健康的年轻和老年肌肉，加上年轻的心脏紧张素II和年轻的肌肉强调AZT治疗。这三种方法的结合使用使我们能够在监测和测量衰老组织中线粒体功能和功能障碍的同时操纵人类线粒体结构和活性。因此，我们可以获得一个综合评估的线粒体，活性氧，能量和蛋白质组学在衰老和疾病的体内相互关系。 公共卫生相关性：这种对挑战06-AG-104的反应结合了三个反应元件，它们将一起使用以提供衰老和疾病中线粒体、ROS、能量学和蛋白质组学的体内相互关系的综合评估：1）我们将通过使用新的线粒体靶向抗氧化剂和保护肽来操纵体内线粒体结构和活性; 2）我们将使用新的磁共振和光谱学工具来创建体内线粒体能量学的完全非侵入性和更通用的测量，以及3）我们将使用新的蛋白质组学工具来表征线粒体功能变化的结构基础。这些方法的组合使用使我们能够在监测和测量衰老组织中线粒体功能和功能障碍的同时操纵人类线粒体结构和活性。